Welcome To Health Pulse

Nicolette 0:00

Welcome to the Health Pulse, your go-to source for quick, actionable insights on health, wellness, and diagnostics. Whether you're looking to optimize your well-being or stay informed about the latest in-medical testing, we've got you covered. Join us as we break down key health topics in just minutes. Let's dive in.

The Hidden Metabolic Breakdown

SPEAKER_02 0:23

Right now, um, millions of people are walking out of their doctor's offices with a high five and a clean bill of health.

SPEAKER_01 0:30

Oh, yeah. Happens every day.

SPEAKER_02 0:32

Because, you know, their fasting blood sugar looks absolutely perfect. But biologically, their metabolism has been silently, frantically breaking down for a decade.

SPEAKER_01 0:43

Right. It's a completely hidden process.

SPEAKER_02 0:45

In the standard medical tests we rely on every single day are just completely blind to this hidden struggle. So today we're looking at the biological exhaust smoke that proves it.

SPEAKER_01 0:56

Aaron Powell We have this really deep-seated reliance on standard glucose numbers, you know, to tell us if we are safe or not.

SPEAKER_02 1:03

Exactly.

SPEAKER_01 1:03

But relying solely on those numbers is, well, it's like waiting for a house to burn down before checking the smoke detector.

SPEAKER_02 1:09

Aaron Powell That is such a stark way to put it, but it makes a lot of sense. And that is the mission of today's deep dive. We are exploring a genuinely paradigm-shifting question.

Nicolette 1:19

Right.

SPEAKER_02 1:19

Can we detect metabolic dysfunction years or maybe even a full decade before someone ever crosses the threshold into what we currently call prediabetes? It's a massive question. It really is. And to figure this out, we are diving deep into a September 2026 report from Quick Lab Mobile. It covers these emerging metabolic biomarkers that are fundamentally changing how we view early detection. Okay, let's unpack this. Because to understand the solution, we first have to understand why our current definition of an early warning is actually incredibly late.

SPEAKER_01 1:54

Yeah. What's fascinating here is that we tend to view prediabetes as the early warning sign. I mean, the very prefix pre implies that we've caught the issue before the real damage begins.

SPEAKER_02 2:04

Right. Like you're in the clear, just need to be careful.

SPEAKER_01 2:06

Exactly. But the biological reality of the human body is completely different. By the time your fasting glucose hits 100 milligrams per deciliter, or your HBA1C creeps up to 5.7%, you aren't at the beginning of a metabolic breakdown.

SPEAKER_02 2:21

Wait, you're not?

SPEAKER_01 2:22

No, not at all. You are at the tail end of a massive compensation process that has likely been happening for 10 years.

SPEAKER_02 2:29

So when a doctor says, you know, your blood sugar is creeping up, let's keep an eye on it. That's not the start of the fire.

SPEAKER_01 2:35

Aaron Powell No, that is the moment the fire has finally burned through the roof.

SPEAKER_02 2:39

Wow.

SPEAKER_01 2:40

Type 2 diabetes rarely happens because your body's glucose regulation just suddenly fails overnight. It develops through this remarkably prolonged, drawn-out battle between insulin resistance and your pancreas trying to compensate for that resistance.

How The Body Compensates For Years

SPEAKER_02 2:53

Let's break down the mechanics of that battle, actually. What is physically happening in my tissues during those 10 years when my lab report says my glucose is totally fine?

SPEAKER_01 3:04

Well, think about your skeletal muscle, your liver, and your adipose tissue, your fat cells. Over time, these tissues can become progressively less responsive to insulin.

SPEAKER_02 3:12

And insulin is basically the key, right?

SPEAKER_01 3:15

Exactly. Insulin acts as the key that unlocks those cells to let glucose in from the bloodstream. When your cells start resisting that key, glucose struggles to get out of the blood.

SPEAKER_02 3:24

Aaron Powell Okay, I follow.

SPEAKER_01 3:26

But your body is incredibly resilient. Your pancreas, specifically the beta cells, it senses this resistance. So its immediate solution is just to work harder.

SPEAKER_02 3:35

Aaron Ross Powell It just forces the issue.

SPEAKER_01 3:36

Aaron Powell Yeah. It pumps out significantly more insulin to forcefully shove those doors open.

SPEAKER_02 3:41

Aaron Powell It sounds like a duck gliding smoothly across a pond. On the surface, your blood sugar looks calm, but underneath, your pancreas is paddling frantically just to keep you afloat.

SPEAKER_01 3:51

Aaron Ross Powell That is a perfect analogy, actually. Yes.

SPEAKER_02 3:54

Aaron Ross Powell But I have to push back a little here. If the pancreas is doing its job and keeping glucose normal, why should we even care about this invisible struggle? I mean, if the blood sugar is stable, who cares how much insulin it took to get there?

SPEAKER_01 4:07

Aaron Powell And that is the crucial trap modern medicine has fallen into. We just assume glucose is the only metric that matters. Right. But this compensated phase, this period where your pancreas is frantically pumping out extra insulin, is actively altering other major systems in your body.

SPEAKER_02 4:23

Aaron Powell Like what?

SPEAKER_01 4:24

Well, it changes your lipid metabolism, it alters your amino acid processing, and it shifts your cellular energy pathways long before the glucose dam actually breaks.

SPEAKER_02 4:33

Aaron Powell So the high insulin itself is causing collateral damage, even if it's technically winning the war on blood sugar.

SPEAKER_01 4:40

Aaron Powell Yes, absolutely. Your skeletal muscle is requiring progressively more insulin just to dispose of the exact same amount of daily glucose. And your liver begins struggling to suppress its own internal glucose production, and your fat cells start leaking more fatty acids into your bloodstream. All of this is happening entirely under the surface. Oh, tons. The Whitehall II cohort study proved this beautifully. They tracked people over a really long period and found that the metabolic changes associated with diabetes, specifically the worsening insulin sensitivity and those massive compensatory spikes in insulin secretion, could be detected years before the sharp deterioration in glucose regulation that leads to an actual diagnosis.

SPEAKER_02 5:21

So the transition into prediabetes isn't the sudden appearance of a disease. It's just the moment your pancreas gets exhausted, waves the white flag, and can't produce enough insulin to hide the underlying dysfunction anymore.

SPEAKER_01 5:34

That's the mechanism, yeah. It's the failure of the compensation. Fasting glucose and HBA1C are lagging indicators.

SPEAKER_02 5:41

Aaron Powell They just tell us when the battle is already lost.

SPEAKER_01 5:43

Aaron Powell Exactly. They tell us when glucose regulation has already failed. They offer zero insight into when the metabolic process leading to that failure actually began.

SPEAKER_02 5:52

Okay. So since our standard tests only show us when the dam finally breaks, we need a way to measure the struggle itself. We need to like listen in on the engine of our metabolism while it's secretly redlining.

SPEAKER_01 6:04

Right.

Meet Alpha Hydroxybutyrate

SPEAKER_02 6:05

And that brings us to the biomarker from the Quick Lab Mobile report. It's called alpha hydroxybutyrate, often abbreviated as alpha HB or sometimes 2HB.

SPEAKER_01 6:15

Yes. And this specific biomarker has researchers rethinking the entire timeline of metabolic disease.

SPEAKER_02 6:21

Now, with a name like alpha hydroxybutyrate, my mind immediately goes to beta hydroxybutyrate, you know, the ketone. Are we looking at a low-carb fat-burning byproduct here?

SPEAKER_01 6:32

It is a totally reasonable assumption, but no. Despite the structural similarity in the name, alpha HB is not a ketone body related to low-carb diets or fasting.

SPEAKER_02 6:42

Okay. Good to know.

SPEAKER_01 6:43

It is also not a type of sugar, and it's not a direct measurement of insulin. It is a small metabolite produced during normal intermediary metabolism.

SPEAKER_02 6:52

Aaron Powell Why does this specific small metabolite show up when our metabolism is silently struggling, though? Like what is the biological

Oxidative Stress And Cellular Exhaust

SPEAKER_02 7:00

trigger?

SPEAKER_01 7:00

Aaron Powell To understand that we have to look at how your cells handle oxidative stress.

SPEAKER_02 7:05

Okay.

SPEAKER_01 7:05

When you develop early insulin resistance, the way your liver, muscle, and fat tissues handle fuel begins to change. The mitochondria, you know, the power plants of your cells, they get overwhelmed.

SPEAKER_02 7:16

Right.

SPEAKER_01 7:16

This altered fuel handling creates a massive amount of oxidative stress. And to fight that stress, your cells desperately need to manufacture a very powerful cellular antioxidant called glutathione.

SPEAKER_02 7:28

Aaron Powell Okay, so the body senses stress and screams for more antioxidants. Where does alpha HB come into this manufacturing process?

SPEAKER_01 7:36

It comes down to how the body actually builds that glutathione. To make this antioxidant, your body acts like a factory running in absolute overdrive.

SPEAKER_02 7:44

Just cranking it out.

SPEAKER_01 7:45

Right. It pushes an amino acid called methionine down a specific biological assembly line. This is called the transulfuration pathway. But when you run a factory at maximum capacity, you generate waste. Of course. As a byproduct of making all this glutathione, the assembly line spits out a molecule called alpha-ketobutyrate.

SPEAKER_02 8:04

And the body obviously has to clean up that byproduct.

SPEAKER_01 8:06

Aaron Powell Precisely. The effort to clean up that alpha-ketobutyrate byproduct is what ultimately drains your cell's battery. The cell converts that byproduct into alpha HB just to get rid of it. Okay. But doing so consumes a critical energy molecule called NADH and converts it into NAD plus.

SPEAKER_02 8:24

Aaron Powell Let's pause there because the ratio of NEDH to NED plus is something that comes up constantly in longevity and metabolism research.

SPEAKER_01 8:32

Oh, absolutely.

SPEAKER_02 8:33

Why does draining that specific battery matter so much here?

SPEAKER_01 8:37

Aaron Ross Powell Because that ratio represents your cellular redox balance. It's essentially the electrical charge status of your cells.

SPEAKER_02 8:44

Got it.

SPEAKER_01 8:45

In an insulin-resistant state, your liver is already overwhelmed with fatty acids. Processing those fatty acids generates way too much NADH.

SPEAKER_02 8:53

Aaron Powell So it's building up.

SPEAKER_01 8:54

Right. The cell is choking on it, and it desperately needs to convert it back to NAD plus just to keep basic cellular functions running. Turning that byproduct into alpha HB solves that immediate electrical problem.

SPEAKER_02 9:07

Aaron Powell I see. So alpha HB isn't the thing causing the metabolic damage. It is exactly like the thick black exhaust smoke coming out of the tailpipe of an overworked engine.

SPEAKER_01 9:18

Exactly.

SPEAKER_02 9:19

You look at the speedometer on your dashboard, which is your blood sugar, and it says you're cruising at a totally normal 60 miles an hour. But that black smoke billowing out the back tells you the engine is tearing itself apart internally just to maintain that speed.

SPEAKER_01 9:32

That is the biological reality.

SPEAKER_02 9:35

When alpha HB levels rise in your blood, it's a massive biochemical signal that your cellular battery balance is completely out of whack. Your pathways are overwhelmed, and your body is generating exhaust smoke to survive. But wait, if this process is driven by oxidative stress and the need for antioxidants, couldn't it just be a false alarm?

SPEAKER_01 9:55

How do you mean?

SPEAKER_02 9:56

Like if I have a terrible week of sleep or I'm fighting off an infection, wouldn't I also have oxidative stress? Is it risky to use this as a warning sign specifically for diabetes?

Proof From Clamps And Cohorts

SPEAKER_01 10:07

Aaron Powell If we connect this to the bigger picture, alpha HB is what we call an associative biomarker. It's true that it is not a direct driver of diabetes itself. Right. However, metabolomic studies have repeatedly put it to the test using the absolute gold standard measurement for insulin resistance. It's a procedure called the hyperinsulinemic euglycemic clamp.

SPEAKER_02 10:29

Which is essentially hooking someone up to IVs and meticulously measuring exactly how much glucose their tissues can absorb in real time, right?

SPEAKER_01 10:36

Exactly. It leaves zero room for guesswork. And when researchers use that clamp, they find that alpha HB is strongly, undeniably tied to insulin resistance. Crucially, this association holds up perfectly even in individuals whose blood glucose hasn't budged an inch toward pre-diabetic levels. It is remarkably specific to this particular type of metabolic gridlock.

SPEAKER_02 10:58

Aaron Powell Okay, so the biological mechanism makes total sense. We know why the engine is smoking. But a mechanism in a lab is one thing. I want to know if there's actual long-term proof that this exhaust smoke translates into a breakdown out on the highway.

SPEAKER_01 11:14

We have that proof, and it comes from a massive long-term cohort study in Sweden known as the Parokrank study. This is arguably the strongest reason to pay attention to this biomarker.

SPEAKER_02 11:24

Aaron Powell Oh, interesting. How did they set it up?

SPEAKER_01 11:27

Aaron Powell The researchers tracked 1,349 participants who had no known diabetes at the start of the study. They took their baseline alpha HB levels along with a vast array of other health metrics, and then they just watched them for nearly a decade.

SPEAKER_02 11:41

Almost 10 years of tracking real human lives. What did the exhaust smoke predict?

SPEAKER_01 11:46

Well, over that decade, 134 of those people developed type 2 diabetes. When the researchers looked back at the baseline blood draws from 10 years prior, they found a distinct, stepwise relationship.

SPEAKER_02 11:58

Aaron Powell Meaning as one went up, the other went up.

SPEAKER_01 12:01

Exactly. For every log unit increase in a person's alpha HB level at the start of the study, they had a 78% higher risk of developing type 2 diabetes a decade later. So a hazard ratio of 1.78.

SPEAKER_02 12:14

Aaron Powell An almost 80% jump in risk is massive. But couldn't you argue that the people with high alpha HB were just the people who are already heavier or whose HBA1C was already hovering at the top end of the normal range?

SPEAKER_01 12:27

Aaron Powell That is the most striking finding of the entire study. That 78% higher risk remained after adjusting for all conventional clinical variables.

Nicolette 12:36

Really?

SPEAKER_01 12:37

Yes. That includes adjusting for body mass index and baseline HBA1C. Alpha HB was not just echoing what the other tests were saying, it was providing entirely independent new information about the future. It actually improved the net reclassification index, the NRI, by 0.23.

SPEAKER_02 12:55

Wait, what does that index actually mean for a patient?

SPEAKER_01 12:58

It basically means the tests successfully corrected the risk prediction for about 23% of the people who would have been totally miscategorized by standard tests.

SPEAKER_02 13:07

So it wasn't just telling you someone was overweight. It was telling you how their cells were actually handling energy.

SPEAKER_01 13:13

Exactly. If you had a room of 100 people who looked totally healthy on standard tests, looking at their alpha HB levels allowed doctors to successfully pull out the 23 people who were secretly

Perfect Fasting Numbers Can Mislead

SPEAKER_01 13:24

on a collision course with diabetes. It reclassified their long-term risk completely under the radar of standard medicine.

SPEAKER_02 13:30

Aaron Powell Here's where it gets really interesting. We are talking about a test that spots hidden danger that fasting tests completely miss. And the source report highlighted even more recent data on this from 2026, correct?

SPEAKER_01 13:42

Aaron Powell Yes, a very complimentary study published in Diabetes Care in September 2026. They looked at 772 individuals and measured their alpha HB levels across the whole spectrum of metabolic health.

SPEAKER_02 13:54

And what did they see?

SPEAKER_01 13:56

The levels rose sequentially as you moved from healthy to sick. The median was 39 micromoles per liter in people with normal glucose. It went up to 51.9 in prediabetes and hit 57 in type 2 diabetes.

SPEAKER_02 14:09

Aaron Powell It scales perfectly with the severity of the dysfunction.

SPEAKER_01 14:13

It does. But the real mic drop moment was when they isolated a specific subset of 534 people who had quote unquote perfect fasting numbers.

SPEAKER_02 14:22

Aaron Powell How perfect are we talking?

SPEAKER_01 14:24

Their fasting glucose was below 110, and their HBA1C was below 5.7%. According to current medical guidelines, these people had absolutely nothing to worry about.

SPEAKER_02 14:34

The exact people getting a high five from their doctor.

SPEAKER_01 14:36

Precisely. But researchers didn't stop at fasting tests. They gave these people an oral glucose tolerance test, an OGTT.

SPEAKER_02 14:44

Aaron Powell, which means drinking a super high sugar beverage and tracking how the body handles it over two hours, right?

SPEAKER_01 14:49

Exactly. And what they found was staggering. In these people with perfect fasting numbers, high alpha HB successfully flagged the individuals who were hiding massive two-hour post-meal glucose spikes.

SPEAKER_02 15:02

So their fasting blood sugar was a total illusion.

SPEAKER_01 15:05

Aaron Powell An illusion maintained by a struggling pancreas. They found an AURC of 0.79 for spotting this hidden dysfunction.

SPEAKER_02 15:12

So basically an 80% accuracy rate in flagging people that fasting tests completely missed.

SPEAKER_01 15:18

Exactly. And for every standard deviation increase in alpha HB, a person had a 2.23 times higher odds of having this hidden dysglycemia. The standard test said everything is fine, but the alpha HB correctly warned that the system couldn't actually handle a real-world metabolic load.

SPEAKER_02 15:36

Aaron Powell That is wild. But we need to be careful with how we interpret this, especially for anyone listening who wants to go get this tested. Prediction is not diagnosis.

SPEAKER_01 15:46

Very true.

SPEAKER_02 15:47

If I take this test tomorrow and get a high score, am I definitively 100% getting diabetes in 10 years? Or is this just a statistical probability?

SPEAKER_01 15:57

That is a critical distinction. High alpha HB does not mean diabetes is inevitable. It is a risk marker, not a crystal ball.

SPEAKER_02 16:05

Aaron Powell Okay. Good to clarify.

SPEAKER_01 16:06

It tells you that you are currently on the metabolic continuum. It tells you your body is actively experiencing the oxidative stress and altered fuel handling associated with insulin resistance. It is a glaring warning light on the dashboard, giving you a massive head start to change course before the engine seizes

New Testing Makes Alpha HB Accessible

SPEAKER_01 16:23

up.

SPEAKER_02 16:23

Aaron Powell Which leads to the most practical question for the listener. Can you actually go out and get this test today? Is this purely for Swedish research scientists or can anyone access this metabolic exhaust monitor?

SPEAKER_01 16:35

Aaron Powell This is where the medical landscape is shifting incredibly fast. Historically, measuring alpha HB was tedious and expensive. It required specialized metabolomic platforms, specifically mass spectrometry.

SPEAKER_02 16:47

Aaron Powell Like trying to run a simple app on a giant room-sized mainframe computer. It's just not practical for a local clinic.

SPEAKER_01 16:54

Aaron Ross Powell Exactly. It was far too complex for routine blood work. But in September 2026, the industry took a massive leap forward. Two companies, Precision Diabetes and DirectSense, announced a U.S. commercial partnership to roll out the MetMark Alpha HB test. Okay. And the genius of this rollout is that it uses a new enzymatic technology called Express GT.

SPEAKER_02 17:16

Why does the shift to an enzymatic test matter so much for accessibility?

SPEAKER_01 17:20

It's the equivalent of moving from building cars by hand, which is slow and massively expensive, to an automated assembly line. This new enzymatic test can run on the standard chemical analyzers that every local hospital and commercial lab already has.

Nicolette 17:34

Oh wow.

SPEAKER_01 17:35

Yeah, you don't need the expensive mass spectrometry equipment anymore. It can be processed just as easily as your standard cholesterol panel.

SPEAKER_02 17:42

That completely removes the bottleneck.

SPEAKER_01 17:44

It does. And the source material points out that the infrastructure for this is already branching out of the clinic entirely. Companies like Quick Lab Mobile down in Miami are currently providing at-home blood draws for a whole suite of these advanced metabolic markers.

SPEAKER_02 17:58

So you don't even have to sit in the waiting room. A phlebotomist just comes to your house?

SPEAKER_01 18:02

Exactly. We are entering an era of decentralized, highly accessible metabolic tracking.

SPEAKER_02 18:08

The friction is just totally gone.

SPEAKER_01 18:10

But this brings up a really important debate.

How To Use Biomarkers Wisely

SPEAKER_01 18:13

Just because we can easily measure this exhaust smoke now, does that mean we should toss out our old tests? Like, are we throwing away the HBA1C and the fasting glucose entirely? This raises an important question, and the answer is an absolute definitive no. Alpha HB does not replace the American Diabetes Association diagnostic criteria.

Nicolette 18:32

Okay.

SPEAKER_01 18:32

You cannot officially diagnose diabetes with alpha HB. You still need fasting glucose, HBA1C, and the oral glucose tolerance test to confirm a diagnosis. And you absolutely still need fasting insulin to fully understand how hard the pancreas is working.

SPEAKER_02 18:47

Aaron Ross Powell Because they're measuring different parts of the timeline.

SPEAKER_01 18:50

Exactly. Let's say a patient comes in with high triglycerides, central obesity, and sky-high fasting insulin. If you test their alpha HB and it comes back high, well, it doesn't really change the treatment plan, right? Right. You already knew they were metabolically sick. You already knew they needed aggressive lifestyle or pharmaceutical intervention. The exhaust smoke is obvious at that point.

SPEAKER_02 19:10

Aaron Powell So who is this actually for? Who benefits the most from knowing this number?

SPEAKER_01 19:15

Aaron Powell The true superpower of alpha HB is for the person we talked about at the very beginning of this deep dive. The person whose conventional glucose markers look totally reassuring, but whose metabolism is quietly failing.

Nicolette 19:27

Right.

SPEAKER_01 19:28

If your HBA1C is a beautiful 5.2 and your fasting glucose is a crisp 85, a standard doctor is going to tell you not to worry. But if your alpha HB is elevated, that is the undeniable signal that your body is compensating furiously to maintain those perfect numbers. It is for the person who wants to intervene before the structural damage becomes permanent.

SPEAKER_02 19:50

It fundamentally changes how we think about health anxiety versus proactive health. Some might say knowing you are at risk 10 years early is just a recipe for anxiety.

The New Take On Metabolic Health

SPEAKER_02 20:00

But really, it's empowering.

SPEAKER_01 20:02

Completely empowering.

SPEAKER_02 20:03

Metabolism isn't a single switch that gets flipped from healthy to diabetic. It's an entire dashboard of gauges. You've got your glucose gauge, your insulin gauge, your lipid gauge, and now we have this alpha HB gauge that monitors the stress on the engine itself.

SPEAKER_01 20:19

That is the perfect way to frame it. People fail in different ways. Some people develop fasting high blood sugar first, others develop post-meal spikes first, others maintain perfect sugar but pump out massive, toxic amounts of insulin for a decade. Right. None of these tests are a perfect universal clock for disease progression. They are simply different windows into an evolving process.

SPEAKER_02 20:43

So what does this all mean? The big takeaway for you listening is that your metabolic health simply cannot be defined by a single glucose number on an annual lab report. Insulin resistance, changes in how your tissues handle fat, and cellular oxidative stress, they all happen on a deeply connected, long-term continuum.

SPEAKER_01 21:03

Yeah, they do.

SPEAKER_02 21:04

And alpha HP is a newly accessible window into the very earliest stages of that continuum.

SPEAKER_01 21:09

The ultimate goal here isn't just to add more numbers to your lab work for the sake of biohacking or obsessing over data. The goal is to find actionable information while your body is still successfully fighting to keep you stable.

SPEAKER_02 21:22

Exactly.

SPEAKER_01 21:22

Because once those standard glucose numbers stay permanently high, your beta cells are already failing. The window for easy lifestyle-driven prevention has likely closed. You want to catch the dysfunction while the compensation is still happening.

SPEAKER_02 21:36

Which brings us back to that doctor's office and that perfectly normal lab result you just got handed. If our bodies are so incredibly adaptable, so stubbornly resilient that they can mask massive metabolic failure from our standard medical tests for a whole decade, what other silent physiological compensations are happening inside of you right now, completely undetected? Just waiting for the right biomarker to finally translate their story.

Nicolette 22:02

Something to think about next time you get a clean bill of health.quicklabmobile.com. Stay informed, stay healthy, and we'll catch you in the next episode.